vs
Alpha Cognition Inc.（ACOG）与Aligos Therapeutics, Inc.（ALGS）财务数据对比。点击上方公司名可切换其他公司
Alpha Cognition Inc.的季度营收约是Aligos Therapeutics, Inc.的16.5倍（$2.8M vs $169.0K）。Alpha Cognition Inc.净利率更高（-245.5% vs -11763.9%，领先11518.4%）
Aligos Therapeutics是一家临床阶段生物制药企业，专注于开发针对流行性肝病与病毒感染的新型靶向疗法，核心管线覆盖慢性乙型肝炎、非酒精性脂肪性肝炎等适应症，通过自主研发推进药物落地，满足全球未被满足的医疗需求。
ACOG vs ALGS — 直观对比
营收规模更大
ACOG
是对方的16.5倍
$169.0K
净利率更高
ACOG
高出11518.4%
-11763.9%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $2.8M | $169.0K |
| 净利润 | $-6.9M | $-19.9M |
| 毛利率 | — | — |
| 营业利润率 | -283.7% | -12907.7% |
| 净利率 | -245.5% | -11763.9% |
| 营收同比 | — | -72.1% |
| 净利润同比 | — | 75.8% |
| 每股收益（稀释后） | $-0.10 | $4.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACOGALGS
| Q4 25 | $2.8M | $169.0K | ||
| Q3 25 | $2.8M | $741.0K | ||
| Q2 25 | $1.7M | $965.0K | ||
| Q1 25 | $2.9M | $311.0K | ||
| Q4 24 | — | $606.0K | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | — | $1.1M | ||
| Q1 24 | — | $694.0K |
净利润ACOGALGS
| Q4 25 | $-6.9M | $-19.9M | ||
| Q3 25 | $-1.3M | $-31.5M | ||
| Q2 25 | $-10.5M | $-15.9M | ||
| Q1 25 | $-2.0M | $43.1M | ||
| Q4 24 | — | $-82.2M | ||
| Q3 24 | — | $-19.3M | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | — | $-34.9M |
毛利率ACOGALGS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 96.7% | — | ||
| Q1 25 | 99.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ACOGALGS
| Q4 25 | -283.7% | -12907.7% | ||
| Q3 25 | -187.0% | -3827.4% | ||
| Q2 25 | -346.1% | -1924.0% | ||
| Q1 25 | -125.9% | -6187.5% | ||
| Q4 24 | — | -3393.2% | ||
| Q3 24 | — | -1610.5% | ||
| Q2 24 | — | -2489.5% | ||
| Q1 24 | — | -3176.7% |
净利率ACOGALGS
| Q4 25 | -245.5% | -11763.9% | ||
| Q3 25 | -46.4% | -4256.0% | ||
| Q2 25 | -632.7% | -1643.8% | ||
| Q1 25 | -68.5% | 13854.7% | ||
| Q4 24 | — | -13556.1% | ||
| Q3 24 | — | -1540.7% | ||
| Q2 24 | — | 477.0% | ||
| Q1 24 | — | -5023.5% |
每股收益（稀释后）ACOGALGS
| Q4 25 | $-0.10 | $4.23 | ||
| Q3 25 | $-0.30 | $-3.04 | ||
| Q2 25 | $-0.65 | $-1.53 | ||
| Q1 25 | $-0.13 | $-2.11 | ||
| Q4 24 | — | $-13.10 | ||
| Q3 24 | — | $-3.07 | ||
| Q2 24 | — | $0.81 | ||
| Q1 24 | — | $-5.58 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $66.0M | $77.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $62.5M | $53.5M |
| 总资产 | $79.7M | $88.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACOGALGS
| Q4 25 | $66.0M | $77.8M | ||
| Q3 25 | $35.4M | $99.1M | ||
| Q2 25 | $39.4M | $122.9M | ||
| Q1 25 | $45.5M | $137.9M | ||
| Q4 24 | — | $56.9M | ||
| Q3 24 | — | $74.9M | ||
| Q2 24 | — | $94.5M | ||
| Q1 24 | — | $112.7M |
股东权益ACOGALGS
| Q4 25 | $62.5M | $53.5M | ||
| Q3 25 | $33.9M | $71.8M | ||
| Q2 25 | $31.9M | $101.9M | ||
| Q1 25 | $40.8M | $116.4M | ||
| Q4 24 | — | $-29.0M | ||
| Q3 24 | — | $50.1M | ||
| Q2 24 | — | $67.2M | ||
| Q1 24 | — | $59.8M |
总资产ACOGALGS
| Q4 25 | $79.7M | $88.5M | ||
| Q3 25 | $46.3M | $109.8M | ||
| Q2 25 | $45.1M | $134.7M | ||
| Q1 25 | $48.6M | $150.7M | ||
| Q4 24 | — | $70.1M | ||
| Q3 24 | — | $88.4M | ||
| Q2 24 | — | $108.8M | ||
| Q1 24 | — | $127.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.9M | $-21.7M |
| 自由现金流经营现金流 - 资本支出 | $-7.1M | — |
| 自由现金流率自由现金流/营收 | -252.6% | — |
| 资本支出强度资本支出/营收 | 5.3% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-20.7M | — |
8季度趋势，按日历期对齐
经营现金流ACOGALGS
| Q4 25 | $-6.9M | $-21.7M | ||
| Q3 25 | $-5.3M | $-24.3M | ||
| Q2 25 | $-6.1M | $-15.5M | ||
| Q1 25 | $-2.0M | $-20.9M | ||
| Q4 24 | — | $-18.4M | ||
| Q3 24 | — | $-20.1M | ||
| Q2 24 | — | $-19.5M | ||
| Q1 24 | — | $-22.7M |
自由现金流ACOGALGS
| Q4 25 | $-7.1M | — | ||
| Q3 25 | $-5.4M | — | ||
| Q2 25 | $-6.1M | — | ||
| Q1 25 | $-2.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ACOGALGS
| Q4 25 | -252.6% | — | ||
| Q3 25 | -188.8% | — | ||
| Q2 25 | -370.9% | — | ||
| Q1 25 | -72.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ACOGALGS
| Q4 25 | 5.3% | — | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ACOGALGS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.49× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -3.85× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
